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Iron deposition in the brain is a feature of normal aging, though in several 3 
neurodegenerative disorders, including Alzheimer’s disease, the rate of iron 4 
accumulation is more advanced than in age-matched controls. Using laser ablation-5 
inductively coupled plasma-mass spectrometry imaging we present here a pilot study 6 
that quantitatively assessed the iron content of white and grey matter in the frontal 7 
cortex of Alzheimer’s and control subjects. Using the phosphorus image as a 8 
confirmed proxy for the white/grey matter boundary, we found that intrusion of iron 9 
into grey matter occurs in the Alzheimer’s brain compared to controls, which may be 10 
indicative of either a loss of iron homeostasis in this vulnerable brain region, or 11 
provide evidence of increased inflammatory processes as a response to chronic 12 
neurodegeneration. We also observed a trend of increasing iron within the white 13 
matter of the frontal cortex, potentially indicative of disrupted iron metabolism 14 
preceding loss of myelin integrity. Considering the known potential toxicity of 15 
excessive iron in the brain, our results provide supporting evidence for the continuous 16 
development of novel magnetic resonance imaging approaches for assessing white 17 
and grey matter iron accumulation in Alzheimer’s disease. 18 




Increased iron deposition in the cerebral cortex of Alzheimer’s disease (AD) brains is 3 
a pathological hallmark of the condition (Hallgren and Sourander, 1960). 4 
Neuroinflammation, where glial cells promote the deposition of iron, contributes to 5 
elevated oxidative stress and mitochondrial dysfunction, and may also promote the 6 
aggregation of the β-amyloid peptide and tau protein, forming the plaques and tangles 7 
characteristic of the disease (Ong and Farooqui, 2005). Combined with the natural 8 
accumulation of iron in the aging brain, endogenous response to elevated cortical iron 9 
(such as heme oxygenase-1, which degrades heme and can release free, reactive 10 
ferrous [Fe2+] iron) may represent an important biochemical mechanism preceding 11 
neuronal damage in AD (Ward et al., 2014). 12 
 13 
In vivo imaging of the AD brain using magnetic resonance imaging (MRI) has 14 
provided useful insight into both structural changes (Bartzokis et al., 2003) and iron 15 
deposition (Bartzokis et al., 2000; Langkammer et al., 2014), using techniques such as 16 
R2 and R2* relaxometery (Langkammer et al., 2010), phase imaging (Zhu et al., 2009) 17 
and quantitative susceptibility mapping (Bilgic et al., 2012). However, differentiation 18 
between white and grey matter iron distribution in the neocortex using MRI is 19 
challenging, as typical MRI approaches are not absolutely quantitative, there are 20 
multiple contributions to tissue contrast (including myelin, iron and CSF), and have a 21 
spatial resolution that precludes fine detail definition of brain iron distribution at 22 
micrometer scales. Because of these many limitations, MR imaging of brain iron has 23 
been largely constrained to deep brain nuclei, such as the basal ganglia, which contain 24 
the highest iron content throughout the brain. 25 
 26 
In this study we employed quantitative iron imaging by laser ablation-inductively 27 
coupled plasma-mass spectrometry (LA-ICP-MS) to compare the distribution of iron 28 
in white and grey matter regions of post mortem AD and healthy control (HC) frontal 29 
cortex tissue which are primarily affected by AD pathology. LA-ICP-MS employs a 30 
focused beam (typically in the ultra-violet range) that ablates particles from the tissue 31 
sample surface, which are then carried to the ICP-MS and measured on the basis of 32 
mass-to-charge (m/z) ratio (Hare et al., 2015). LA-ICP-MS is highly specific and 33 
sensitive to iron, with detection limits well below the typical biological concentrations 34 
 4 
found in neurological tissue (O'Reilly et al., 2014). With appropriate signal 1 
normalization and periodic sampling of standards with comparable matrix 2 
composition, LA-ICP-MS can provide absolute quantitative information at the low 3 
micrometer scale (1-100+ µm) (Hare et al., 2012a; Miliszkiewicz et al., 2015). As an 4 
element-specific detector, LA-ICP-MS also permits simultaneous detection of 5 
multiple analytes and generation of hyperspectral images. We exploited this capability 6 
here by using phosphorus distribution as a proxy for white and grey matter, which 7 
was then applied to differentiating iron distribution in the two regions of frontal 8 
cortex tissue from both AD and HC brains. 9 
 10 
Materials and methods: 11 
 12 
Human brain samples 13 
 14 
Formalin fixed and paraffin embedded AD (n = 4) and HC (n = 5) frontal cortex 15 
tissue was obtained from the Victorian Brain Bank Network at the Florey Institute of 16 
Neuroscience and Mental Health. All procedures were conducted in accordance with 17 
the Australian National Health and Medical Research Council’s National Statement 18 
on Ethical Conduct in Human Research (2007), the Victorian Human Tissue Act 19 
(1982), the National Code of Ethical Autopsy Practice (2002) and the Victorian 20 
Government policies and practices in relation to post mortem tissue. All tissue 21 
samples were previously genotyped and confirmed as apolipoprotein E3/E3 allele 22 
carriers (Rembach et al., 2013). Subject details are given in Tables 1 and 2. Previous 23 
studies have shown that formalin fixation may effect absolute iron concentrations 24 
(Hackett et al., 2011; Hare et al., 2014a), particularly during long-term (approx. 4 25 
years) storage of brain tissue (Schrag et al., 2010). However, storage in formalin for 26 
shorter periods (<18 months) was shown to have no effect on brain iron levels 27 
(Gellein et al., 2007). Regardless, all samples underwent identical preparation 28 
methods (fixation of whole brain in 20% neutral buffered formalin for <6 weeks prior 29 
to neuropathological examination, excision of tissue blocks, paraffin infiltration and 30 
embedding) to ensure relative comparisons were valid. 31 
 32 
 5 
Table 1: Subject age, sex and post mortem interval details. Neither age (p = 0.2; 1 
Student’s two-tailed t-test) nor post mortem interval (p = 0.3) differed between 2 
groups. 3 
 4 
 Alzheimer’s disease Healthy control 
Age (years) 74.2 ± 8.0 (n = 4) 85.4 ± 2.1 (n = 5) 
Male (female) 4 (0) 4 (1) 
Post mortem interval (hours) 47.9 ± 11.9 34.5 ± 5.7 
 5 
Table 2: Disease duration, cause of death and AD family history (where applicable). 6 
 7 
Case Disease duration Cause of death Family history 
AD1 ~ 4 years, 6 months 
(early onset at ~ 49 
years) 
Pulmonary thromboembolism; deep vein 
thrombosis 
Mother AD onset in 
her 70s, grandmother 
also had AD 
AD2  ~ 4 years Dementia  Not known 
AD3 Unsure (never saw 
regular doctor); 
minimum 4 yrs 
Acute septicaemia; dementia Mother AD onset in 
her late 80s 
AD4 Diagnosed 18 months 
prior to death, date of 
onset not known 
Multiple myeloma; cerebral arteriosclerosis No family history 
HC1 n/a Cardiac tamponade – haemopericardium, ruptured 
acute posterolateral left; ventricular myocardial 
infarction; ischaemic coronary artery disease 
 
HC2 n/a Acute myocardial infarction; ischaemic heart 
disease; hypertension 
 
HC3 n/a Acute myocardial infarction  
HC4 n/a Complications of surgical correction of fractured 
neck of femur; general debility; hepatic abscess; 
ischaemic heart disease; chronic renal failure 
 
HC5 n/a Ischaemic Heart Disease  
 8 
 9 
Sample preparation for LA-ICP-MS 10 
 11 
Sections were cut on a standard microtome at 5-µm thickness and mounted on silane-12 
coated soda-glass microscope slides (StarFrost®; ProSciTech, Qld, Australia). 13 
Sections were dewaxed in xylene (Merk Millipore, NSW, Australia) and decreasing 14 
concentrations of ethanol (Merk Millipore) in water according to standard protocols. 15 
Samples were finally washed in MilliQ water (18.2 MΩ; Merk Millipore) and dried at 16 
room temperature before analysis.  17 
 18 
LA-ICP-MS analysis 19 
 20 
 6 
Quantitative imaging of iron was performed using a NewWave NWR213 laser 1 
ablation system (ESI Ltd., Bozeman, MT, USA) hyphenated to an Agilent 2 
Technologies 8800 Series triple quadrupole ICP-MS (Mulgrave, VIC, Australia) 3 
operating in single quadrupole acquisition mode with 3 mL min-1 hydrogen reaction 4 
gas to minimize polyatomic interference from 40Ar16O+ on 56Fe+ (Lear et al., 2012). 5 
The NWR213 was fitted with a standard two-volume cell with a 10 cm x 10 cm 6 
scanning area. Standard operating parameters for this system were used as previously 7 
reported (Bishop et al., 2015). Mass-to-charge (m/z) ratios for carbon (13), 8 
phosphorus (31) and iron (56) were acquired. Samples were ablated using a square 80 9 
x 80 µm laser beam, producing pixels representing a total area of 6.4 mm2 with a laser 10 
energy fluence of approximately 1 J cm-2, which was sufficient to ablate tissue but not 11 
the underlying slide matrix. Signal noise accounted for approximately 0.3% of the 12 
mean signal intensity for each section, and was thus considered negligible. 13 
Phosphorus and iron data was normalized to the corresponding carbon-13 signal 14 
recorded to compensate for variation in laser power and sample transport effects 15 
(Austin et al., 2011). Iron images were quantitated against representative ablation 16 
(carbon-13 normalized) of matrix-matched tissue standards produced using metal-17 
spiked homogenates of sheep cortical brain tissue cut to an equivalent thickness on a 18 
cryostat (Hare et al., 2013b). Four repeated five-point calibrations were recorded 19 
during the experiment, with good linearity (r2 = 0.9485) and reproducibility (p = 20 
0.4677; F = 0.909; Supplementary Fig. S1). Images were produced using ENVI 5.3 21 
(Exelis, Boulder, CO, USA), background (scanned areas not containing tissue) pixels 22 
excluded using a carbon-13 mask, and regions of interest (ROIs) were extracted using 23 
both ENVI 5.3 and Fiji (http://fiji.sc/Fiji, (Schindelin et al., 2012)). Statistical analysis 24 
of extracted ROIs was performed using Prism 6.0e (GraphPad, La Jolla, CA, USA) 25 
 26 
Perls staining 27 
 28 
Adjacent 5-μm thick sections mounted on microscope slides were dewaxed as above, 29 
and then extensively rinsed in running water. Hydrated sections were incubated at 37 30 
°C for 1 hour in potassium ferrocyanide (7% w/v) in hydrochloric acid (3% v/v) and 31 
then enhanced using a solution of 3.5 μM 3,3’-diaminobenzidine (DAB) in hydrogen 32 
peroxide (0.015% v/v) for 5 minutes. After quenching the reaction by immersing in 33 
running water, samples were counterstained with hemotoxylin for 2 minutes and 34 
 7 
washed in water before dehydration in increasing ethanol concentration, xylene and 1 
coverslipping. Micrographs were recorded using a Leica DM2500 optical microscope 2 
with a 2.5×/0.50 NA lens and Leica DFC310FX digital camera.  3 
 4 
Myelin staining 5 
 6 
Myelin was histologically stained on additional adjacent 5-µm thick sections using the 7 
Luxol Fast Blue method. Sections were dewaxed and stained in 0.1% (w/v) Luxol 8 
Fast Blue in methanol with 0.05% (v/v) acetic acid for 1 hour. White and grey matter 9 
was differentiated in 0.05% (w/v) lithium carbonate for approximately 4 minutes. 10 
Sections were then counterstained with Cresyl Violet for 1 hour, dehydrated, cleared 11 
in xylene and coverslipped. Micrographs were recorded the same equipment as 12 




Quantitative images of iron in the AD and HC sections are presented in Fig. 1a 17 
(shown here on the same scale, see Supplementary Fig. S2 for individually scaled 18 
images). In AD tissue, total iron was elevated compared to control (mean iron 19 
concentration AD = 18.80 ± 2.23 µg g-1; HC = 12.80 ± 1.17 µg g-1; p < 0.05, 20 
Student’s two-tailed t-test; Fig. 1b). Perls staining with DAB enhancement (Fig. 1a) 21 
revealed only minor non-heme iron deposition within white matter. Iron could be 22 
associated with three specific distribution patterns in both AD and HC tissue in each 23 
LA-ICP-MS image related to both grey and white matter myelin content: i) cortical 24 
‘bands’ of tangentially oriented, myelinated fiber tracts (e.g. Bands of Baillarger), 25 
consistent with layer-specific MR contrast variations attributed to the co-localization 26 
of these myelin bands with iron (Fukunaga et al., 2010); ii) subcortical U-fibers found 27 
directly adjacent to the white-grey matter boundary (Drayer et al., 1986); and iii) non-28 
homogenous pattern in subcortical white matter in the form of a diffuse, patchwork 29 
distribution previously reported using immunohistochemistry by Connor and Menzies 30 
(Connor and Menzies, 1995) and in subsequent mouse studies using LA-ICP-MS 31 




Fig. 1. A) Quantitative LA-ICP-MS imaging of total iron levels in AD and HC frontal 2 
cortex sections and corresponding Perls images from selected regions of interest. Perls 3 
staining with DAB enhancement revealed only minor intracellular increases in iron 4 
content visible within the white matter of AD brains, mirroring the ‘streaking’ pattern 5 
within these regions observed in LA-ICP-MS images, which was less obvious in age-6 
matched HCs. Red arrows indicate subcortical iron, yellow arrows indicate cortical 7 
iron (see Supplementary Fig. S2). B) The total frontal cortex iron levels were 8 
significantly increased (*; p < 0.05; Student’s two-tailed t-test) in the AD sections. 9 
Error bars = 1 standard deviation between samples. Note: the white arrow indicates 10 
iron-rich caudate nucleus in one section, which was confirmed by Luxol Fast Blue 11 
staining and was excluded from the analysis. 12 
 13 
To demarcate the white-grey matter boundary, we used images of phosphorus (Fig. 14 
2a; Supplementary Fig. S3), which has been shown to effectively depict spatial 15 
myelin distribution using micro particle induced X-ray emission spectroscopy 16 
(µPIXE) with myelin immunostaining as a confirmatory comparator (Stüber et al., 17 
2014), and is more concentrated in white matter (Duyn et al., 2007). LA-ICP-MS 18 
imaging is hyperspectral, where iron and phosphorus signal corresponds between 19 
pixels. A white matter mask was produced by a threshold function using bimodal 20 
distribution of phosphorus pixels. A grey matter mask was then produced using the 21 
remaining pixels with the white matter values excluded. This mask was then applied 22 
 9 
to iron images (Fig. 3). We confirmed that phosphorus imaging by LA-ICP-MS also 1 
delineated white and grey matter with Luxol Fast Blue staining of myelin (Fig. 2a). 2 
There was no apparent difference in relative phosphorus distribution between AD and 3 
HC groups (WMAD
 = 2.53 ± 0.24, WMHC = 2.53 ± 0.05, p = 1.0; GMAD = 1.50 ± 0.14, 4 
GMHC = 1.55 ± 0.06; p = 0.7; all units carbon-13 normalized phosphorus signal 5 
intensity; Supplementary Fig. S4). Iron was present at a lower concentration in grey 6 
matter of the HC frontal cortex (WMHC = 15.1 ± 1.7 µg g
-1; GMHC = 10.5 ± 1.1 µg g
-1; 7 
p < 0.05; iron concentrations for each section are shown in Table 2), though in 8 
corresponding AD sections the demarcation of iron distribution within white and grey 9 
matter was lost (WMAD = 18.7 ± 3.7 µg g
-1; GMAD = 15.7 ± 2.2 µg g
-1; p = 0.7). 10 
Comparing white and grey matter between AD and HC tissue, we found that iron was 11 
significantly elevated in the grey matter of AD brains (+49%; p < 0.05), and showed a 12 
generalized, non-significant increasing trend in white matter (+25%; p = 0.4; Fig. 2b). 13 
It is unclear as to why errors associated with iron in AD tissue were generally larger 14 
than HC samples, though we have observed that cellular iron dyshomeostasis, such as 15 
is thought to be involved in AD pathology, demonstrates a more variable 16 




Fig. 2. A) Myelin staining using the Luxol Fast Blue method confirms phosphorus 2 
imaging by LA-ICP-MS differentiates white (red arrows) and grey matter (blue 3 
arrows). B) Using the phosphorus images to delineate the white/grey matter boundary 4 
and simultaneously obtained iron LA-ICP-MS images, iron levels were quantified 5 
according to white/grey matter distribution. Iron levels in white matter did not differ 6 
significantly between experimental groups, though iron was significantly increased in 7 
the grey matter of the AD frontal cortex (*; p < 0.05; Student’s two-tailed t-test). 8 
Also, the significant difference between white and grey matter in healthy controls (^; 9 
p < 0.05) was not observed in AD tissue sections (p = 0.5). 10 
 11 
 12 
Fig. 3: Masks were generated using high (white matter; red line) and low phosphorus 13 
signal intensity values, which were then applied to quantitative iron images to extract 14 
white and grey matter regions of interest. 15 
 16 
 11 
Table 3: Individual iron concentrations (± 1 standard deviation) and total measured 1 
area in whole brain, white matter and grey matter for AD and HC sections analysed.  2 
 3 
 Whole brain White matter Grey matter 
Case Iron (μg g-1) Area (mm2) Iron (μg g-1) Area (mm2) Iron (μg g-1) Area (mm2) 
AD1 15.0 ± 13.2 150.2 13.8 ± 5.2 44.3 15.6 ± 7.2 105.9 
AD2 19.1 ± 12.1 171.2 19.5 ± 4.7 69.3 17.1 ± 6.3 101.9 
AD3 23.5 ± 18.9 168.5 28.9 ± 10.8 94.2 20.2 ± 8.7 74.3 
AD4 10.6 ± 4.4 188.4 12.8 ± 2.8 129.8 9.8 ± 3.6 58.6 
HC1 8.4 ± 4.9 180.1 9.0 ± 3.0 55.2 7.2 ± 4.1 124.9 
HC2 15.3 ± 6.8 155.7 16.4 ± 4.8 41.6 13.4 ± 7.9 114.1 
HC3 13.8 ± 7.0 173.3 19.5 ± 5.1 130.3 12.0 ± 5.0 43.0 
HC4 13.0 ± 4.1 146.1 14.3 ± 3.8 67.8 11.0 ± 4.0 78.2 





Previously reported iron levels in digests of formalin-fixed frontal white matter, 8 
measured using solution nebulization ICP-MS, were markedly higher than our results; 9 
iron concentrations were ~50% of those reported in fixed frontal lobe tissue reported 10 
by others (Langkammer et al., 2012a; Langkammer et al., 2012b). However, leaching 11 
did not appear to be specific to cortical tissue; the iron concentration in the caudate 12 
nucleus excluded from our analysis (33.0 ± 10.9 µg g-1) showed a similar degree of 13 
iron loss compared to non-embedded tissue (Langkammer et al., 2012b). To our 14 
knowledge, the effects of paraffin embedding and deparaffinization on brain iron 15 
levels has not been reported, though a study comparing fresh liver tissue to paraffin 16 
infiltrated and dewaxed samples showed a linear relationship between iron 17 
concentrations in lieu of absolute quantitative reproducibility (Beilby et al., 1999). 18 
Regardless, and as stated in the Methods and Materials, all samples underwent 19 
identical preparation steps to ensure valid comparisons. While it is possible that an 20 
altered chemical environment with respect to iron in AD tissue is more susceptible to 21 
post mortem artefact, such as leaching during the fixation and embedding process, the 22 
hypothesis that neurotoxicity in AD is related to an increased labile iron pool (i.e. 23 
Fe2+) (Peters et al., 2015) is supported by our data, which shows elevated iron levels 24 
are preserved in AD tissue even after extensive chemical treatment. However, 25 
speciation of iron is not practical for archived tissue sections nor this analytical 26 
approach; fresh unfixed tissue and species-specific imaging such as X-ray absorption 27 
 12 
near-edge structure (XANES) spectroscopy would be required for this task (James et 1 
al., 2016). 2 
 3 
Although subcortical white matter contains some of the lowest concentration of iron 4 
within the brain (Riederer et al., 1989), particularly compared to the basal ganglia 5 
(Hare et al., 2012b)., and corresponding cortical grey matter also contains 6 
comparatively less non-heme iron (Hallgren and Sourander, 1960). Our results from 7 
age-matched healthy controls show that cortical grey matter contains less total iron 8 
than adjacent white matter. These data are in agreement with historical values; 9 
Hallgren and Sourander (1958) reported that the ratio of iron in frontal white matter to 10 
temporal cortex was 1.3, and we observed a similar ratio of 1.5. 11 
 12 
Our results highlight some of the known limitations of MRI for assessing brain iron 13 
levels. Myelin is known to introduce significant bias in magnetic susceptibility MRI 14 
(Lodygensky et al., 2012), with this bias strongest in myelin-rich white matter. Field 15 
dependent relaxation rate increase (FDRI) MRI is more robust to ferritin iron content, 16 
although is susceptible to registration error between scanning sessions (Daugherty and 17 
Raz, 2015). Thus, in vivo assessment of iron accumulation is often most suited to 18 
diseases affecting areas of natively high iron and low myelin content, such as the 19 
basal ganglia in Parkinson’s disease (Rossi et al., 2013). 20 
 21 
This is not to say that iron concentration in the cerebral white matter does not play a 22 
significant role in brain aging and age-related disorders like AD. Numerous 23 
histological and MRI studies have identified significant age-related changes first 24 
appearing in the cerebral white matter (Gunning-Dixon et al., 2009). R1 with diffusion 25 
MRI of white matter measured over a large cohort spanning 80 years identified a slow 26 
decline beginning at 40+ years of age (Yeatman et al., 2014). Central to the brain iron 27 
deposition and free radical theory of aging is that a loss of iron homeostasis results in 28 
the accumulation of reactive iron(II), which mediates the generation of harmful 29 
reactive oxygen species (ROS) (Schipper, 2004). This occurrence may not necessarily 30 
result in a measure of accumulation of iron. Rather, the redistribution of iron from 31 
safe storage in proteins like ferritin to the cytoplasm may be sufficient to initiate a 32 
cascading Fenton reaction, where iron repeatedly cycles through the ferrous and ferric 33 
oxidation states to produce a constant source of free radicals that eventually 34 
 13 
overwhelm endogenous antioxidant mechanisms (Hare et al., 2013a). Therefore, 1 
lower iron levels in white matter compared to the deep brain structures of the basal 2 
ganglia should not be viewed as an insignificant contributor to either normal brain 3 
aging, or age-related neurodegeneration, such as AD. White matter is particularly 4 
lipid-rich, and thus highly susceptible to peroxidation and loss of cellular and 5 
structural integrity in AD (Bartzokis et al., 2003). 6 
 7 
The generalized increase in cortical grey matter iron in our pilot study lends further 8 
support to iron playing a critical role in neurodegeneration within the AD brain. 9 
Disrupted iron metabolism, such as impaired activity of the amyloid precursor protein 10 
(Duce et al., 2010), which is essential to the stabilization of the membrane-bound iron 11 
export protein ferroportin (Wong et al., 2014), can lead to an increase in the labile 12 
iron pool within neurons, facilitating increased ROS generation. When combined with 13 
R2 relaxometry, FDRI MRI has shown a relationship between iron accumulation in 14 
ferritin and loss of tissue integrity in the hippocampus of AD patients (Raven et al., 15 
2013). Iron has also been associated with accumulation around extracellular amyloid 16 
plaques in humans (Connor et al., 1992a; Lovell et al., 1998). Our LA-ICP-MS 17 
technique likely lacks the resolution to discern these microscopic structures (Lovell et 18 
al.’s study used micro-particle induced X-ray emission spectroscopy with a per-pixel 19 
resolution of 50 µm2), though a study using X-ray fluorescence microscopy with a 20 
similar resolving power (60 µm2) found elevated extracellular iron in the PSAPP 21 
mouse model of AD that displays similar plaque pathology was not associated with 22 
the β-amyloid inclusions (Leskovjan et al., 2011).  23 
 24 
Intrusion of iron into the grey matter of AD frontal cortex supports MRI studies that 25 
have identified a loss in grey matter density (used as a proxy for atrophy) that 26 
correlates with cognitive decline (Frisoni et al., 2002) and occurs at an increased rate 27 
in AD (Thompson et al., 2003). Increased iron in the grey matter may indicate either a 28 
loss of iron homeostasis, or a brain region at higher risk of iron-mediated 29 
neurodegeneration. Previous studies of iron regulatory proteins in cortical tissue 30 
found a generalized decrease in transferrin levels in grey matter and consistent 31 
distribution of ferritin (Connor et al., 1992b). This may be indicative a higher degree 32 
of ferritin saturation as a compensatory mechanism for increased grey matter iron, 33 
though Perls staining did not reveal an observable amount of increased non-heme iron 34 
 14 
within this region. Another possible scenario reflective of increased grey matter iron 1 
is the inflammatory process underway within the degenerating region. In vitro studies 2 
of astrocytes and microglia cultured from post mortem AD white and grey matter has 3 
shown grey matter-sourced cells proliferate more rapidly than white matter 4 
counterparts (Blasko et al., 2004). Our hypothesis is supported by a recent study using 5 
high field 7 Tesla MRI and histological assessment (via the same Perls-DAB method 6 
employed here) of post mortem AD tissue, which showed correlation between grey 7 
matter iron and activated microglia in AD, as well as a similar staining within white 8 
matter (Zeineh et al., 2015). This pattern of non-heme iron is consistent with elevated 9 
levels of ferritin within white matter (Fukunaga et al., 2010; van Duijn et al., 2013), 10 
and the more prominent Perls staining in AD tissue may also be reflective of the 11 
pathological accumulation of this iron storage protein previously observed in the 12 
hippocampus (Raven et al., 2013), preceding a loss of structural integrity in the frontal 13 
cortex white matter occurring later in the disease. Chronic inflammation is a cardinal 14 
feature of AD (Gomez-Nicola and Boche, 2015) and neurodegeneration in general 15 
(De Lucia et al., 2015), and targeting inflammatory pathways and microglial 16 
activation is a promising avenue for therapeutic development (Olmos-Alonso et al., 17 
2016). Our observed increase in iron levels within the degenerating grey matter 18 
supports that this region is under duress and initiates a response mechanism highly 19 
dependent on iron-mediated enzymatic processes, which in turn has a follow-on effect 20 
on oligodendrocyte health and myelin integrity in white matter. Further, 21 
hypometabolism (which is associated with iron deposition and white matter damage 22 
in the aceruloplasmenic brain (Miyajima et al., 2002)) occurs prior to atrophy in AD 23 
white matter (Chételat et al., 2008), with the frontal cortex displaying loss of integrity 24 




We have demonstrated that post mortem analysis of frontal cortex tissue from AD and 29 
HC subjects displays a marked change in cortical grey matter iron distribution in this 30 
degenerating region of the brain. Although this method is only possible using post 31 
mortem tissue, we present important supporting evidence for existing MRI studies that 32 
have focused on discerning white and grey matter iron distributions in vivo using a 33 
highly sensitive and quantitative imaging approach. Results from this study highlight 34 
 15 
a further need to understand the mechanisms by which iron may impart neurotoxicity 1 
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